National Health Investors, Inc. NHI

66.92 (0.24) (0.36%) as of 25 Sep
Market cap
$3.3B
P/E
19.3×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
25.20 22.07 17.79 35.94 23.55 16.71 22.14 20.47 19.43 19.22
P/S ratio
9.53 9.07 7.55 8.50 8.80 9.29 11.12 10.75 11.12 11.71
P/FCF ratio
0.00 54.24 12.59 6.89 6.58 19.94 938.63 52.61 136.21 0.00
P/Operating CF
52.85 52.78 45.40 51.03 49.24 55.58 63.01 61.46 59.44 61.48
P/B ratio
2.34 2.21 1.91 1.85 1.73 2.03 2.36 2.28 2.34 2.41
Price to Tangible BV
2.34 2.21 1.91 1.85 1.73 2.03 2.36 2.28 2.34 2.41
EV/Sales
12.58 12.41 11.03 12.56 12.83 13.66 15.63 15.09 15.22 16.18
EV/EBITDA
16.75 15.93 14.01 21.42 17.51 14.55 16.58 15.90 15.69 17.92
EV/Operating CF
19.97 20.02 19.13 18.85 18.18 19.59 20.64 21.39 21.41 22.76
EV/FCF
(82.20) 74.27 18.38 10.18 9.60 29.33 1,319.43 73.82 186.42 (21.12)
Quick Ratio
2.25 2.95 3.12 3.71 5.76 5.52 3.47 5.54 6.16 3.70
Current Ratio
6.90 10.07 10.27 12.71 18.70 17.13 16.40 17.92 14.84 10.09
Net Debt/EBITDA
4.06 4.29 4.42 6.92 5.51 4.66 4.79 4.57 4.23 4.95
Debt/Assets
41.61% 43.84% 45.61% 45.76% 43.78% 48.05% 47.35% 46.60% 45.00% 46.43%
Debt/Equity
0.76 0.83 0.90 0.90 0.82 0.98 0.96 0.92 0.87 0.92
Asset Turnover
0.14 0.13 0.13 0.10 0.10 0.11 0.11 0.11 0.11 0.11
Operating CF/Net income
1.67 1.51 1.36 2.79 1.89 1.25 1.50 1.35 1.24 1.17
Capex/Depreciation
(3.41) (1.95) 0.10 1.93 2.21 (0.87) (2.88) (1.96) (2.42) (5.88)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
9.77% 10.45% 10.66% 4.75% 7.36% 12.26% 11.11% 11.38% 12.59% 12.89%
ROA
5.25% 5.40% 5.43% 2.48% 3.75% 6.01% 5.54% 5.83% 6.44% 6.68%
ROIC
4.57% 4.59% 4.66% 2.11% 3.06% 4.70% 4.64% 4.78% 5.02% 4.36%
Return on Tangible Assets
5.20% 5.40% 5.59% 2.74% 4.10% 6.02% 5.41% 5.71% 6.35% 6.45%
Average Days of Receivables
76.66 94.90 96.68 100.89 117.54 104.96 98.74 130.85 127.53 106.53
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
7.86% 6.50% 6.20% 9.10% 6.47% 4.37% 4.37% 4.36% 4.56% 4.10%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.48% 1.25% 1.44% 3.10% 2.82% 0.92% 1.15% 0.85% 0.94% 0.70%
Graham Net Nets
(0.27) (0.28) (0.36) (0.38) (0.34) (0.38) (0.31) (0.32) (0.32) (0.34)
Graham Number
47.17 47.08 45.30 30.75 42.68 56.34 53.45 52.45 53.26 52.03
Earnings Yield
3.97% 4.53% 5.62% 2.78% 4.25% 5.99% 4.52% 4.88% 5.15% 5.20%
Free Cash Flow Yield
(1.61%) 1.84% 7.95% 14.51% 15.20% 5.02% 0.11% 1.90% 0.73% (6.54%)
Revenue per Share
8.01 7.64 7.37 6.21 6.53 7.45 7.33 7.02 6.81 6.37
Operating CF per Share
5.05 4.74 4.25 4.14 4.61 5.19 5.55 4.96 4.84 4.53
Capex per Share
(6.27) (3.46) 0.17 3.53 4.12 (1.72) (5.46) (3.52) (4.29) (9.41)
Free Cash Flow per Share
(1.23) 1.28 4.42 7.67 8.74 3.47 0.09 1.44 0.56 (4.88)
Cash per Share
0.42 0.55 0.52 0.43 0.82 0.97 0.12 0.11 0.07 0.12
Shareholders Equity per Share
32.63 31.37 29.14 28.59 33.18 34.07 34.51 33.13 32.33 31.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
32.63 31.37 29.14 28.59 33.18 34.07 34.51 33.13 32.33 31.00
Free Cash Flow
(57.47) 56.02 191.93 343.31 399.38 155.06 3.77 60.22 22.75 (190.38)
Working Capital
258.08 342.61 318.03 303.42 410.38 406.29 405.09 336.50 225.61 189.77
Capital Expenditures
(294.03) (151.75) 7.48 157.97 188.52 (77.09) (237.19) (147.64) (175.34) (367.01)
Net Current Asset Value
(965.37) (858.62) (871.76) (898.02) (888.33) (1,166.07) (1,112.58) (1,004.47) (981.80) (983.40)
EV/EBIT
24.15 22.71 19.92 43.00 28.73 20.31 22.86 21.78 21.44 24.84
Capex to Sales
0.78 0.45 (0.02) (0.57) (0.63) 0.23 0.75 0.50 0.63 1.48
Net Profit Margin
37.80% 41.13% 42.40% 23.87% 37.43% 55.62% 50.45% 52.39% 57.19% 60.99%
Price to Operating Income
18.30 16.59 13.64 29.11 19.70 13.81 16.26 15.52 15.67 17.97
Other line items
Depreciation/Fixed assets
0.03 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03
Cash ROIC
(82.46%) (78.70%) (79.39%) (78.99%) (75.32%) (79.44%) (78.79%) (80.68%) (84.50%) (85.11%)
Accounts Receivable Turnover
4.52 3.90 3.96 3.21 3.11 3.66 3.32 2.90 3.28 3.76
Accounts Payable Turnover
1.50 1.17 1.32 1.15 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 — — — — — —
Average Days of Payables
262.00 326.18 316.29 335.38 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
0.00 0.00 0.00 0.00 — — — — — —
Average Receivables
83.02 85.93 80.80 86.55 95.95 90.87 95.83 101.49 84.94 66.15
Average Payables
40.75 36.03 30.10 24.54 24.19 25.75 23.10 18.10 18.59 20.51
Average Assets
2,705.63 2,551.43 2,497.95 2,673.15 2,979.68 3,081.36 2,896.40 2,648.20 2,474.73 2,268.43
Average Common Equity
1,452.55 1,319.89 1,272.24 1,398.53 1,519.96 1,510.60 1,443.98 1,355.92 1,265.85 1,176.03

Fold the line items

Columns are period end dates